A Cobaltocenium–Peptide Bioconjugate Shows Enhanced Cellular Uptake and Directed Nuclear Delivery
Authors:
- Fozia NoorFNFozia Noor
- Ralf KinscherfRKRalf Kinscherf
- Nils Metzler‐NolteNMNils Metzler‐Nolte
- 13 April 2005
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 44 (16) , 2429-2432
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Iron‐Containing Nucleoside Analogues with Pronounced Apoptosis‐Inducing ActivityAngewandte Chemie International Edition, 2004
- Investigations on the effects of cobalt-alkyne complexes on leukemia and lymphoma cells: cytotoxicity and cellular uptakeJournal of Inorganic Biochemistry, 2004
- Positively Charged DNA-Binding Proteins Cause Apparent Cell Membrane TranslocationBiochemical and Biophysical Research Communications, 2002
- Labeling of Biomolecules for Medicinal Applications—Bioorganometallic Chemistry at Its BestAngewandte Chemie International Edition, 2001
- Enhanced anti-cancer activities of some derivatives of titanocene dichlorideJournal of Inorganic Biochemistry, 2001
- Transport Between the Cell Nucleus and the CytoplasmAnnual Review of Cell and Developmental Biology, 1999
- Design of Carrier Peptide-Oligonucleotide Conjugates with Rapid Membrane Translocation and Nuclear Localization PropertiesBiochemical and Biophysical Research Communications, 1998
- Bioorganometallic Chemistry – Synthesis and Antitumor Activity of Cobalt Carbonyl ComplexesArchiv der Pharmazie, 1997
- Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell linesEuropean Journal of Cancer, 1993
- Titanocen-dichlorid - das erste Metallocen mit cancerostatischer WirksamkeitAngewandte Chemie, 1979